Company intelligence
Innitius
Quantifying cervical biomechanics for OBGYN
About Innitius
Innitius is a medtech company focused on bringing a new diagnostic dimension to women’s health through cervical biomechanics. Our platform combines a CE-marked medical device with AI-based decision support to provide objective and quantitative assessment of cervical tissue, complementing existing ultrasound-based approaches. Designed to complement ultrasound, the technology captures biomechanical changes that are not visible through imaging alone. The company works with a growing network of leading hospitals across Europe and is expanding its clinical programs through multicenter studies across different applications in OBGYN. Innitius is advancing clinical validation while progressively scaling its presence in clinical practice.
Verified activity
Signals from Innitius
3 published signals
Showing the latest saved company activity while the live feed reconnects.
Legal & Regulatory
Innitius CerviSense platform is CE-marked and listed on the Voluson Solution Store by GE healthcare.
Reported by Innitius
Products & Services
Innitius CerviSense, a device for measuring mechanical stiffness of the cervix, is now CE-marked and distributed through the Voluson Solution Store by GE HealthCare.
Reported by Innitius
Research & Knowledge
Innitius is currently validating CerviSense's ability to flag risk earlier for threatened preterm labor and support precise triage for patients needing treatment to delay labor.
Reported by Innitius